General Session III | Expanding Obesity Treatment and Care

Tuesday, May 20, 2025

3:45 PM - 5:00 PM ET

Location: Tampa Bay 1-5

Moderator(s)

Dorothea K. Vafiadis, MS, FAHA

Senior Director
National Council on Aging

Panelist(s)

Scott Biggs

Director, Supplier Services
IQVIA
Deanna Horner, PharmD, BCPS

Senior Vice President, Chief Pharmacy Officer
Waltz Health
Lia Rodriguez, MD FAAP

Chief Medical Officer
CVS Healthspire Payor Solutions/CVS Health
Sara Roszak, DrPH, MPH

Senior Vice President, Health & Wellness Strategy & Policy
National Association of Chain Drug Stores (NACDS)

The prevalence of obesity continues to rise, and health care systems, health plans, life sciences companies, and pharmacies are all affected. This session will explore the implications of obesity as a covered disease, and how organizations are managing care, including medications. Gain insights from various perspectives on anti-obesity medications (AOMs), wraparound services, the CMS proposal to permit coverage of AOMs, and the future of this disease state and its care models.